St. Jude Medical, Inc. http://www.alacrastore.com/company-snapshot/St_Jude_Medical_Inc-1059158 Friday, July 25, 2008 6:33:10 PM 1059158 St. Jude Medical, Inc. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/BW-0001-26905086newstex/BW-0001-26905086xml Jul. ##, #### (Business Wire) -- Four free stock picks are being made available today on Zacks.com. The industrya€™s leading independent research firm highlights one Zacks ## Rank Strong Buy or a Zacks ## Rank Buy stock for each of...0400000004009000040020000400200604016000040160180401604807000000070030000700300107014000070140127/24/2008 3:06:32 PM180000001800400018008000Business WireBW-0001-26905086ABBOTT LABORATORIESCHILDRENS PLACE RETAIL STORES INCPOSCOST JUDE MEDICAL INCABTPKXPLCESTJNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1787657ccbn/T1787657norm...Welcome to St. Jude Medical's first quarter #### earnings conference call. Hosting the call today is Mr. Dan Starks, Chairman, President and Chief Executive Officer of St. Jude Medical. The remarks made during this conference call include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of #### that involve risks and uncertainties. Such forward-looking statements include the expectations, ... 7/16/2008 5:10:59 PMSt. Jude Medical, Inc.54.0000Q1 2008 St. Jude Medical, Inc. Earnings Conference Call/St. Jude Medical to Acquire EP MedSystemsSTJ9:00AM ETTranscriptT1787657Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1787657ccbn/B1787657norm...GAAP requires co. to estimate and record effective income tax rate assuming R&D tax credit is not extended.... 7/16/2008 5:10:49 PMSt. Jude Medical, Inc.54.0000Q1 2008 St. Jude Medical, Inc. Earnings Conference Call/St. Jude Medical to Acquire EP MedSystemsSTJ9:00AM ETBriefB1787657Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1882479ccbn/B1882479norm...For this call and calculation of adjusted net earnings, assumes tax credit will be extended for ####. ... 7/16/2008 1:10:48 PMSt. Jude Medical, Inc.106.0000EditedQ2 2008 St. Jude Medical, Inc. Earnings Conference Call SummarySTJ8:00am ETBriefB1882479Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1882479ccbn/T1882479norm...Welcome to St. Jude Medical second quarter #### earnings conference call. Hosting the call today is Dan Starks, Chairman, President and Chief Executive Officer of St. Jude Medical. The remarks made during this conference call include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of #### that involve risks and uncertainties. Such forward-looking statements include the expectations, plans, and prospects for St. Jude Medical. The statements made on this Conference Call are based upon current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such statements involve potential risks and uncertainties, such as market conditions and other factors beyond St. Jude Medical's control and the risk factors and other cautionary statements described in St. Jude Medical's filings with the SEC, including those described in the risk factors... 7/16/2008 11:12:00 AMSt. Jude Medical, Inc.106.0000FinalQ2 2008 St. Jude Medical, Inc. Earnings Conference Call TranscriptSTJ8:00am ETTranscriptT1882479Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-26399123newstex/BW-0001-26399123xml Jul. #, #### (Business Wire) -- In the fourth paragraph of the release, the first sentence should read: As previously announced, the Election Deadline was # p.m. EDT, July #, #### (sted As previously announced, the Election Deadline...0400000004016000040160050200000002002000020020060700000007014000070140097/2/2008 1:06:11 PM180000001801600018020000Business WireBW-0001-26399123EP MEDSYSTEMS INCST JUDE MEDICAL INCEPMDSTJNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-26298093newstex/BW-0001-26298093xml Jun. ##, #### (Business Wire) -- St. Jude Medical, Inc. (NYSE:STJ) will hold its quarterly conference call to discuss Second Quarter #### results on Wednesday, July ##th at #:## a.m. Eastern Time (#:## a.m. Central Time). A news release...040000000401600004016048040160180700000007014000070140096/27/2008 5:08:27 PM180000001800400018008000Business WireBW-0001-26298093ST JUDE MEDICAL INCSTJNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-24968173newstex/BW-0001-24968173xml ST. PAUL, Minn., May #, #### (Business Wire) -- St. Jude Medical, Inc. (NYSE:STJ) today announced a partnership with the Microsoft Corp. Health Solutions Group to research the integration of data from implantable devices with patient-controlled,...0700000007013000070100000400000004006000040060050400300004003005040160000401600107014000070140095/2/2008 9:08:16 AM1800000018022000190000001900100019001023Business WireBW-0001-24968173MICROSOFT CORPST JUDE MEDICAL INCGeorge NULL FazioMSFTSTJNewsNewstexhttp://www.alacrastore.com/storecontent/spcred/645942spcred/645942normThe latest News from S&Pglobal5/2/2008 2:51:23 AM100News645942United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareNewsNEW YORK (Standard&Poor's) May 1, 2008--Standard&Poor's Ratings Services said today it raised its corporate credit rating on St. Jude Medical Inc. to 'A-' from 'BBB+'. The outlook is stable. The upgrade reflects the company's resilience through difficult industry conditions, as well as its growing revenue base, improving financial profile, and continued steady performance across all product lines. "The rating on St. Jude reflects the company's portfolio of leading medical devices, which generates solid cash flow, and its conservative financial policies and strong debt protection measures," said Standard&Poor's credit analyst Cheryl Richer. "These factors mitigate the company's vulnerability to technological changes in its relatively narrow disease focus areas, the risks of competing with larger andUSA79084935101010 351010 3510 35St. Jude Medical Inc.108445USASTJNEWSGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/645943spcred/645943normThe latest Research Update from S&Pglobal5/2/2008 2:51:23 AM175Research Update645943United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareResearch UpdateOn May 1, 2008, Standard&Poor's Ratings Services raised its corporate credit rating on St. Jude Medical Inc. to 'A-' from 'BBB+'. The outlook is stable. The upgrade reflects the company's resilience through difficult industry conditions, as well as its growing revenue base, improving financial profile, and continued steady performance across all product lines. The rating on St. Paul, Minn.-based St. Jude reflects the company's portfolio of leading medical devices, which generates solid cash flow, and its conservative financial policies and strong debt protection measures. These factors mitigate the company's vulnerability to technological changes in its relatively narrow disease focus areas, the risks of competing with larger and diversified rivals, and its exposure to reimbursement risk/pricing pressures typical forUSA79084935101010 351010 3510 35St. Jude Medical Inc.108445USASTJRESUPDGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/newstex/MCOM-0004-24932398newstex/MCOM-0004-24932398xml May #, #### (M# Communications Ltd. delivered by Newstex) -- XETA Technologies (Nasdaq:XETA), a provider of converged voice and data communications solutions for the enterprise marketplace, announced on Wednesday (## April) that Richard...09000000090150000400000004016000040160085/1/2008 6:06:19 AM1800000018007000M2 EquityBitesMCOM-0004-24932398MICROSOFT CORPST JUDE MEDICAL INCXETA TECHNOLOGIES INCRICHARD R DEVENUTIMSFTSTJXETANewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1816712ccbn/T1816712norm... - Analyst - Morgan Stanley. Good afternoon, everyone. Glenn Reicin -- this is Glenn Reicin for those on the webcast. With me is Dan Starks, Chairman, President and CEO of St. Jude Medical. That's a lot of titles. That's definitely going to be a question later. But, while we first start off just maybe two minutes and maybe you can give us just an update on where you think you are relative to your plan this year and with the first quarter behind you and -- ... 5/1/2008 12:12:00 AMSt. Jude Medical, Inc.54.0000FinalSt. Jude Medical, Inc. at Morgan Stanley 2008 Global Healthcare Unplugged Conference TranscriptSTJ3:40pm ETTranscriptT1816712Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/BW-0001-24649695newstex/BW-0001-24649695xml ST. PAUL, Minn., Apr. ##, #### (Business Wire) -- St. Jude Medical, Inc. (NYSE:STJ) today announced it has been awarded a patent from the U.S. Patent and Trademark Office for treating depression using neurostimulation therapy in an...0700000007010000070140000701401307014009070140190400000004006000040060050401600004016001040160310200000002002000020020081100000011001000110010024/21/2008 9:07:33 AM180000001801800019000000190010001900102319001013Business WireBW-0001-24649695ST JUDE MEDICAL INCSTJNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-24538279newstex/BW-0001-24538279xml ST. PAUL, Minn., Apr. ##, #### (Business Wire) -- St. Jude Medical, Inc. (NYSE: STJ) today reported sales and net earnings for the first quarter ended March ##, ####. First Quarter Results The Company reported net sales of $#.###...0400000004016000040160480401600104016018040160470700000007014000070140091300000013001000130010024/16/2008 9:07:34 AM180000001800800018004000190000001900100019001023Business WireBW-0001-24538279ST JUDE MEDICAL INCDANIEL J STARKSSTJNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-24370830newstex/BW-0001-24370830xml ST. PAUL, Minn. & WEST BERLIN, N.J., Apr. #, #### (Business Wire) -- St. Jude Medical, Inc. (NYSE: STJ) and EP MedSystems, Inc. (NASDAQ: EPMD) announced today that the Boards of Directors of both companies have unanimously approved...090000000901500004000000040160000401600504016009040160080401601807000000070140000701400902000000020020000200200618000000180160001801100018020000190000001900100019001023Business Wire4/9/2008 8:06:09 AMBW-0001-24370830EP MEDSYSTEMS INCST JUDE MEDICAL INCDANIEL J STARKSDavid NULL BruceJUDE MEDICAL INC STEPMDSTJNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-24273834newstex/BW-0001-24273834xml ST. PAUL, Minn., Apr. #, #### (Business Wire) -- St. Jude Medical, Inc. (NYSE:STJ) will hold its quarterly conference call to discuss First Quarter #### results on Wednesday, April ##th at #:## a.m. Eastern Time (#:## a.m. Central Time)....04000000040160000401604804016018070000000701400007014009180000001800800018004000190000001900100019001023Business Wire4/4/2008 6:08:12 PMBW-0001-24273834ST JUDE MEDICAL INCSTJNewsNewstexhttp://www.alacrastore.com/storecontent/bir/308110bir/308110normSt. Jude Medical Inc.Epicor Medical, Inc.United StatesManufacturing: Heart valves.384538423345103391132417IKSTJ3/8/2008 6:11:00 AM308110Company Profiles & FinancialsGale Company Profileshttp://www.alacrastore.com/storecontent/spcred/630191spcred/630191normThe latest Full Report from S&P2/11/2008 1:25:27 PMFull Report400global630191United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareFull ReportPosition as a large global manufacturer of leading high-technology content medical devices; Extensive product patenting and strong research and development (R&D) program; Robust cash flow, which supports reinvestment and financial flexibility; and Relatively conservative financial policies. Subject to technological change and obsolescence risks; Faces competitors (including large companies) with better operating diversification and strong financial resources; and Lacks disease-state diversification. The rating on St. Paul, Minn.-based St. Jude Medical Inc. reflects its portfolio of leading medical devices, which generates solid cash flow, and its conservative financial policies and strong debt-protection measures. These factors mitigate the company's vulnerability to technological change within its relatively narrow disease focus areas (cardiology), the risks of competing with larger and diversified rivals, and its exposureUSA79084935101010 351010 3510 35St. Jude Medical Inc.108445USASTJFULLGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/630192spcred/630192normThe latest Summary from S&P2/11/2008 1:25:27 PMSummary175global630192United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareSummaryThe rating on St. Paul, Minn.-based St. Jude Medical Inc. reflects its portfolio of leading medical devices, which generates solid cash flow, and its conservative financial policies and strong debt-protection measures. These factors mitigate the company's vulnerability to technological change within its relatively narrow disease focus areas (cardiology), the risks of competing with larger and diversified rivals, and its exposure to reimbursement risk/pricing pressures typical for health care industry participants. Debt leverage, which was 1.4x for the 12 months ended Sept. 30, 2007, continues to improve as a result of EBITDA growth. St. Jude makes cardiac rhythm management (CRM) devices (63% of sales), including implantable cardioverter defibrillators (ICDs) and pacemakers, as well as heart valves, electrophysiology catheters, vascular sealing devices,USA79084935101010 351010 3510 35St. Jude Medical Inc.108445USASTJSUMMARYGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/627406spcred/627406normThe latest Research Update from S&P1/24/2008 7:18:46 PMResearch Update175global627406United StatesHealth Care EquipmentUnited StatesGlobal IssuersCorporationsHealth CareResearch UpdateOn Jan. 24, 2008, Standard&Poor's Ratings Services revised the outlook on St. Jude Medical Inc. to positive from stable. We affirmed the 'BBB+' corporate credit rating and other ratings on the company. These actions reflect the company's resilience through difficult industry conditions and its improving financial profile. The rating on St. Paul, Minn.-based St. Jude reflects its portfolio of leading medical devices, which generates solid cash flow, and its conservative financial policies and strong debt-protection measures. These factors mitigate the company's vulnerability to technological change within its relatively narrow disease focus areas (cardiology), the risks of competing with larger and diversified rivals, and its exposure to reimbursement risk/pricing pressures typical for health care industry participants. Debt leverage, whichUSA79084935101010 351010 3510 35St. Jude Medical Inc.108445USASTJRESUPDGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Research